Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
3001
DELISTED
Mersana Therapeutics
MRSN
| $1.07M | ﹤0.01% |
4,534
-2,885
| -39% | -$843K |
|
3002
NMI Holdings
NMIH
$3.33B
| $1.07M | ﹤0.01% |
47,275
-4,441
| -9% | -$97.7K |
|
3003
News Corp Class B
NWS
$16.9B
| $1.07M | ﹤0.01% |
45,960
+19,761
| +75% | +$452K |
|
3004
Oxford Industries
OXM
$566M
| $1.07M | ﹤0.01% |
11,832
-6,401
| -35% | -$583K |
|
3005
WillScot Mobile Mini Holdings
WSC
$4.39B
| $1.06M | ﹤0.01% |
33,595
+15,622
| +87% | +$451K |
|
3006
Horace Mann Educators
HMN
$2.1B
| $1.06M | ﹤0.01% |
26,684
-6,264
| -19% | -$248K |
|
3007
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $1.06M | ﹤0.01% |
31,380
-25,295
| -45% | -$801K |
|
|
AVID
3008
DELISTED
Avid Technology Inc
AVID
| $1.06M | ﹤0.01% |
36,575
+913
| +3% | +$28.2K |
|
3009
PUT
AbCellera Biologics
ABCL
$1.74B
| $1.06M | ﹤0.01% |
52,700
-50,000
| -49% | -$884K |
|
|
OOTO
3010
DELISTED
Direxion Daily Travel & Vacation Bull 2X Shares
OOTO
| $1.05M | ﹤0.01% |
50,000
| – | – |
|
3011
Sibanye-Stillwater
SBSW
$6.26B
| $1.05M | ﹤0.01% |
85,471
+66,154
| +342% | +$1.03M |
|
|
B
3012
DELISTED
Barnes Group Inc.
B
| $1.05M | ﹤0.01% |
25,293
-1,540
| -6% | -$73.3K |
|
3013
PUT
Incyte
INCY
$24.2B
| $1.05M | ﹤0.01% |
+15,300
| New | +$1.16M |
|
|
MNTV
3014
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.05M | ﹤0.01% |
53,562
+11,072
| +26% | +$225K |
|
3015
Axcelis
ACLS
$4.01B
| $1.05M | ﹤0.01% |
22,299
-7,311
| -25% | -$318K |
|
3016
Radian Group
RDN
$5.18B
| $1.05M | ﹤0.01% |
46,071
-777,259
| -94% | -$17.6M |
|
3017
Invesco New York AMT-Free Municipal Bond ETF
PZT
$138M
| $1.04M | ﹤0.01% |
40,188
+8,530
| +27% | +$225K |
|
3018
ITT
ITT
$17.5B
| $1.04M | ﹤0.01% |
12,139
-3,314
| -21% | -$311K |
|
3019
Recursion Pharmaceuticals
RXRX
$1.59B
| $1.04M | ﹤0.01% |
45,294
+44,288
| +4,402% | +$1.26M |
|
3020
Castle Biosciences
CSTL
$855M
| $1.04M | ﹤0.01% |
15,628
+1,918
| +14% | +$135K |
|
|
FTAA
3021
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
| $1.04M | ﹤0.01% |
+105,000
| New | +$1.04M |
|
|
CHX
3022
DELISTED
ChampionX
CHX
| $1.03M | ﹤0.01% |
46,282
+11,711
| +34% | +$268K |
|
3023
HealthEquity
HQY
$8.41B
| $1.03M | ﹤0.01% |
15,981
+42
| +0.3% | +$2.92K |
|
3024
Lakeland Financial Corp
LKFN
$1.56B
| $1.03M | ﹤0.01% |
14,506
-203
| -1% | -$13.2K |
|
3025
Syndax Pharmaceuticals
SNDX
$1.69B
| $1.03M | ﹤0.01% |
54,064
-159,296
| -75% | -$2.65M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.